RecruitingNot ApplicableNCT04699591

Compassionate Use of Domperidone for Refractory Gastroparesis

Sponsor

Jose Cocjin

Enrollment

20 participants

Start Date

Apr 1, 2013

Study Type

INTERVENTIONAL

Conditions

Gastroparesis Gastroesophageal Reflux GERD

Summary

The purpose of this program is to allow the use of domperidone in children from 12 to 21 years of age with symptoms related to motility disorders and Gastroesophageal reflux disease (GERD) who have failed all the standard treatments for their condition.

Eligibility

Min Age: 12 YearsMax Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Domperidone for people with gerd, gastroesophageal reflux, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 12 Years to 21 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.